Specialty Pharma Company Could Reward Traders With a Quick Pop

by Sam Collins | January 7, 2013 1:59 am

Specialty Pharma Company Could Reward Traders With a Quick Pop

Allergan (NYSE:AGN[1]) — This California-based specialty pharmaceutical company appears to have it all, including great new products: Botox to treat urinary incontinence and enlarged prostate; DARPin, a new treatment for scalp hair growth; and Voluma, an innovative dermal filler.

It also has $2.9 billion in cash versus $1.5 billion of long-term debt. Analysts’ consensus earnings estimates for 2012 are $4.19, up from $3.01 in 2011. They look for $4.75 in 2013, and S&P sees earnings of $5.55 in 2014.

Last week, the stock broke from a quadruple-top following a nine-month consolidation as it popped from $94 to $98 in two days. Aggressive buyers may want to take a half position now and add on a pullback. Long-term investors could be rewarded by holding for 12 months with a goal of $125. Traders could see a quick move to $106.

01 07 12 agn 300x216 Specialty Pharma Company Could Reward Traders With a Quick Pop
Click to Enlarge

chart key 300x84 Specialty Pharma Company Could Reward Traders With a Quick Pop

Endnotes:
  1. AGN: http://studio-5.financialcontent.com/investplace/quote?Symbol=AGN

Source URL: http://investorplace.com/2013/01/trade-of-the-day-allergan-nyse-agn/
Short URL: http://invstplc.com/1nGRZM8